KalVista Pharmaceuticals Inc (NASDAQ:KALV) Surging 2.22% In 6 Months – Here’s What To Expect
KalVista Pharmaceuticals Inc (NASDAQ:KALV)’s traded shares stood at 0.68 million during the last session, with the company’s beta value hitting 0.13. At the close of